C
Corvus Pharmaceuticals
CRVS
2.96000
USD
0.36
(13.85%)
مفتوح الان
حجم التداول
53,988
الربح لكل سهم
0
العائد الربحي
0
P/E
-18
حجم السوق
488,525,505
الأخبار
العنوان: Corvus Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).